Nektar Therapeutics (NKTR)
74.72
-2.27
(-2.95%)
USD |
NASDAQ |
Apr 06, 16:00
74.80
+0.08
(+0.11%)
After-Hours: 20:00
Nektar Therapeutics SG&A Expense (TTM) : 68.67M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Boston Scientific Corp. | 6.888B |
| Eli Lilly & Co. | 11.09B |
| Soleno Therapeutics, Inc. | 132.13M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Rigel Pharmaceuticals, Inc. | 115.90M |